- The most common cancer in Canadian men
- 1 in 6 Canadian men will be diagnosed in their lifetime
- This year alone, 25,500 men will be diagnosed with the disease in Canada
- Over 90% curable if detected and treated in earliest stages
The PSA Controversy
In the past few months, there have been many media reports discussing the validity of a prostate specific antigen (PSA) test – a simple blood test that may help men and their doctors assess the risk of developing prostate cancer through early detection.
Prostate Cancer Canada is a strong supporter of PSA testing as one form of early detection. We suggest that men and their doctors take the time to discuss the merits of the PSA test, followed by a digital rectal examination (DRE). We strongly recommend that men over 40 establish a baseline PSA value and men over 50 consider annual or semi-annual PSA monitoring.
Like most cancer diagnostic tools, the PSA blood test comes with its pros and cons. We believe that men deserve the right to make their own decisions regarding their health – even if that decision is to forego or delay treatment. Without regular PSA blood tests and DRE’s, it is impossible to make an informed decision assessing the likelihood of cancer.
The usefulness of the PSA test will continue to be debated in political and medical circles. However, men should be aware of the facts and take into account age, risk factors and general health. Learn more about the PSA test.
Prostate Cancer Canada is the only national foundation dedicated to the elimination of this disease through research, education, support and awareness.
